Hello, Fool! | Login | Signup | My Fool
Nov 23, 2008 4:48 AM ET | Feedback | Site Changes | Help
An Australian specialty pharmaceutical company focused on the development of new products for the diagnosis and treatment of chronic respiratory and inflammatory/autoimmune diseases.
View All Commentary (PXSL)
Recs
Tophinater (< 20) Submitted: 8/03/07 3:08 PM : Start Price: $40.50 PXSL Score: -28.88
If they can get their drugs into the Asian market, they should do well.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK